ICP-490 | m-entrepreneurship.com

Product Name :
ICP-490

Search keywords :
IKZF3

drugId :
null

Target Vo:
Ubiquitin-protein ligases

Target Vo Short Name :
Ubiquitin-protein ligases

Moa_Name:
Ubiquitin-protein ligases modulators

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
InnoCare Pharma Ltd

Active Company_Name :
Beijing Innocare Pharma Tech Co Ltd

Active Indication_Name:
Multiple Myeloma

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:
Phase 2 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-eIF4E (Ser209) Antibody
DYKDDDDK Tag (FLAG) Antibody
MMP1 Antibody: MMP1 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 54 kDa, targeting to MMP1. It can be used for WB,IP assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts